Trial Summary
What is the purpose of this trial?
This trial is testing if virtual reality (VR) can help manage chronic pain in patients with type-3 Sphincter of Oddi dysfunction (SOD III). These patients often do not respond to usual treatments and risk opioid addiction. VR creates an engaging 3D experience that distracts the brain from pain. The study aims to see if this method can reduce pain and lower opioid use. Virtual reality (VR) has been shown to effectively manage both acute and chronic pain by providing cognitive distractions and potentially reducing opioid use.
Do I have to stop taking my current medications for the trial?
The trial does not specify if you need to stop taking your current medications. However, if you are on antidepressants for pain control, you should have been taking them for at least one month before the trial. If you are receiving treatment for depressive or anxiety disorders, your medication dose must be stable for at least 6 weeks before the trial.
What data supports the idea that Virtual Reality for Sphincter of Oddi Dysfunction is an effective treatment?
The available research does not provide specific data supporting the effectiveness of Virtual Reality for Sphincter of Oddi Dysfunction. The studies focus on other treatments for this condition and discuss the challenges in diagnosing and treating it. There is some research on Virtual Reality for urinary incontinence, showing improvements in muscle function and quality of life, but these results are similar to traditional methods. More research is needed to determine if Virtual Reality is effective for Sphincter of Oddi Dysfunction.12345
What safety data exists for Virtual Reality therapy?
The available research indicates that Virtual Reality (VR) therapy is generally safe across various applications. In a study involving older adults with cognitive and physical impairments, no negative side effects were reported, and participants tolerated the VR experience well. Another study on VR therapy for anxiety disorders showed a deterioration rate of 4.0%, which is comparable to other therapeutic approaches and lower than waiting list control groups. However, the safety and effectiveness of VR combined with an omnidirectional walking platform remain unclear, as further research is needed to assess these aspects.678910
Is Virtual Reality a promising treatment for Sphincter of Oddi Dysfunction?
The research articles provided do not mention Virtual Reality as a treatment for Sphincter of Oddi Dysfunction. They focus on other treatments like endoscopic procedures and surgery. Therefore, there is no information to suggest that Virtual Reality is a promising treatment for this condition.1451112
Research Team
Simon Lo, MD
Principal Investigator
Cedars-Sinai Medical Center
Eligibility Criteria
This trial is for adults with chronic pain from Sphincter of Oddi Dysfunction (SOD) who haven't found relief through usual treatments. They should not have liver, pancreas, or bile duct issues and must be stable on any antidepressants or psychopharmacologic drugs for at least one month. Participants need to speak English and have access to a cell phone.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Virtual Reality (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Cedars-Sinai Medical Center
Lead Sponsor
David E. Cohen
Cedars-Sinai Medical Center
Chief Medical Officer
MD and PhD in Physiology and Biophysics from Harvard University
Peter L. Slavin
Cedars-Sinai Medical Center
Chief Executive Officer
MD from Harvard Medical School, MBA from Harvard Business School